Discovery of PSMA-specific peptide ligands for targeted drug delivery
Authors:
- 1 November 2016
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 513 (1-2) , 138-147
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMXProceedings of the National Academy of Sciences, 2009
- Identification and Rational Redesign of Peptide Ligands to CRIP1, A Novel Biomarker for CancersPLOS Computational Biology, 2008
- Coexpression of Vascular Endothelial Growth Factor and Interleukin-1 Receptor Antagonist for Improved Human Islet Survival and FunctionMolecular Pharmaceutics, 2007
- A Dimeric Peptide That Binds Selectively to Prostate-Specific Membrane Antigen and Inhibits its Enzymatic ActivityCancer Research, 2006
- In Vivo Selection of Phage for the Optical Imaging of PC-3 Human Prostate Carcinoma in MiceNeoplasia, 2006
- Prostate-Specific Membrane Antigen Regulates Angiogenesis by Modulating Integrin Signal TransductionMolecular and Cellular Biology, 2006
- Cell type–specific delivery of siRNAs with aptamer-siRNA chimerasNature Biotechnology, 2006
- In vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in Brain Tumor XenograftsCancer Research, 2004
- Novel Peptide Inhibitors of Angiotensin-converting Enzyme 2Journal of Biological Chemistry, 2003
- A dual-monoclonal sandwich assay for prostate-specific membrane antigen: Levels in tissues, seminal fluid and urineThe Prostate, 2000